Predicting clinical benefit from continuation of cyclin dependent kinase (CDK) 4/6 inhibitors beyond progression
@article{ATM112589, author = {Julia Foldi and Adam Brufsky}, title = {Predicting clinical benefit from continuation of cyclin dependent kinase (CDK) 4/6 inhibitors beyond progression}, journal = {Annals of Translational Medicine}, volume = {11}, number = {9}, year = {2023}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/112589} }